These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1149 related items for PubMed ID: 28320612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S, Balachandran A, Katz M, Reddy A, Rohren E, Bhosale P.
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [Abstract] [Full Text] [Related]

  • 5. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K.
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [Abstract] [Full Text] [Related]

  • 6. Positron-emission tomography pitfalls related to oral prosthesis.
    More Y, Dusing R, Counts S, Bond J, Tsue T, Girod D.
    Laryngoscope; 2013 Feb; 123(2):404-6. PubMed ID: 22778055
    [Abstract] [Full Text] [Related]

  • 7. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR, Choi YJ, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [Abstract] [Full Text] [Related]

  • 8. Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma.
    Cho JK, Ow TJ, Lee AY, Smith RV, Schlecht NF, Schiff BA, Tassler AB, Lin J, Moadel RM, Valdivia A, Abraham T, Gulko E, Neimark M, Ustun B, Bello JA, Shifteh K.
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ, Kim YM, Jung PS, Lee JJ, Kim JK, Kim YT, Nam JH.
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. F-18 positron emission tomography and computed tomography image-fusion for image-guided detection of local recurrence in patients with head and neck cancer using a 3-dimensional navigation system: a preliminary report.
    Feichtinger M, Aigner RM, Kärcher H.
    J Oral Maxillofac Surg; 2008 Jan; 66(1):193-200. PubMed ID: 18083440
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
    Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM.
    Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
    [Abstract] [Full Text] [Related]

  • 16. Restaging [18F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significance.
    Mahajan S, Barker CA, Mauguen A, Singh B, Pandit-Taskar N.
    J Am Acad Dermatol; 2020 Apr; 82(4):878-886. PubMed ID: 31562942
    [Abstract] [Full Text] [Related]

  • 17. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
    Lavely WC, Scarfone C, Cevikalp H, Li R, Byrne DW, Cmelak AJ, Dawant B, Price RR, Hallahan DE, Fitzpatrick JM.
    Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
    [Abstract] [Full Text] [Related]

  • 18. Preoperative image fusion of fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography data sets in oral maxillofacial carcinoma: potential clinical value.
    Wolf G, Nicoletti R, Schultes G, Schwarz T, Schaffler G, Aigner RM.
    J Comput Assist Tomogr; 2003 May; 27(6):889-95. PubMed ID: 14600456
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
    Kim JH, Heo SH, Kim JW, Shin SS, Min JJ, Kwon SY, Jeong YY, Kang HK.
    World J Gastroenterol; 2017 Sep 21; 23(35):6448-6456. PubMed ID: 29085194
    [Abstract] [Full Text] [Related]

  • 20. Real-Time US-18FDG-PET/CT Image Fusion for Guidance of Thermal Ablation of 18FDG-PET-Positive Liver Metastases: The Added Value of Contrast Enhancement.
    Mauri G, Gennaro N, De Beni S, Ierace T, Goldberg SN, Rodari M, Solbiati LA.
    Cardiovasc Intervent Radiol; 2019 Jan 21; 42(1):60-68. PubMed ID: 30288593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.